The Reply - 16/08/18
Doi : 10.1016/j.amjmed.2018.04.003
Larry A. Weinrauch, MD a, b, c, d, John A. D'Elia, MD b, c, d, Matthew R. Weir, MD e, Suphamai Bunnapradist, MD f, Peter V. Finn, MD a, Jiankang Liu, MD, PhD a, Brian Claggett, PhD a, Anthony P. Monaco, MD c, d, g
a Cardiovascular Division, Brigham and Women's Hospital, Boston, Mass
b Kidney and Hypertension Section, Joslin Diabetes Center, Boston, Mass
c Departments of Medicine andSurgery,Beth Israel Deaconess Medical Center, Boston, Mass
d Harvard Medical School, Boston, Mass
e Division of Nephrology, Departmentof Medicine, University of Maryland School of Medicine, Baltimore
f Division of Nephrology, Departmentof Medicine, University of Californiaat Los Angeles, Los Angeles
g Division of Nephrology, New EnglandMedical Center, Tufts UniversitySchool of Medicine, Boston,Mass
El texto completo de este artículo está disponible en PDF.
| Funding: None |
|
| Conflict of Interest: None |
|
| Authorship: Each of the authors has fully participated and has approved the final manuscript. Each author has reviewed and is responsible for the content. |
© 2018
Publicado por Elsevier Masson SAS.
Vol 131 - N° 8
P. e349-e351 - août 2018 Regresar al número
Artículo precedente
- New Onset Diabetes After Transplant: Data from the Folic Acid for Vascular Outcome Reduction in Transplantation Trial
- Amisha Wallia, Mark E. Molitch
- Pilot Randomized Controlled Trial to Reduce Readmission for Heart Failure Using Novel Tablet and Nurse Practitioner Education
- Khadijah Breathett, Scott Maffett, Randi E. Foraker, Rod Sturdivant, Kristina Moon, Ayesha Hasan, Veronica Franco, Sakima Smith, Brent C. Lampert, Sitaramesh Emani, Garrie Haas, Rami Kahwash, Ray E. Hershberger, Philip F. Binkley, Laura Helmkamp, Kathryn Colborn, Pamela N. Peterson, Nancy Sweitzer, William T. Abraham
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?